Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study
Authors
Keywords
-
Journal
Internal and Emergency Medicine
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-10-21
DOI
10.1007/s11739-020-02523-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SARS-CoV-2: a potential novel etiology of fulminant myocarditis
- (2020) Chen Chen et al. HERZ
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
- (2020) Xintian Xu et al. Science China-Life Sciences
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Angiotensin‐converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS‐CoV‐2: A double‐edged sword?
- (2020) Tiantian Yan et al. FASEB JOURNAL
- Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
- (2020) Guang Yang et al. HYPERTENSION
- The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies
- (2020) Adriana Albini et al. Internal and Emergency Medicine
- Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
- (2020) Riccardo Sarzani et al. Internal and Emergency Medicine
- Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection
- (2020) Brandon Michael Henry et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
- (2020) Ankit B. Patel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
- (2020) Graziano Onder et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis
- (2020) Long‐quan Li et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized COVID-19 Patients
- (2020) Christina C. Price et al. CHEST
- Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis
- (2020) Yong Hu et al. JOURNAL OF CLINICAL VIROLOGY
- Beta Blockers Prevent Correlation of Plasma ACE2 Activity With Echocardiographic Parameters in Patients With Idiopathic Dilated Cardiomyopathy
- (2015) Yong Wang et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies
- (2014) Guang Hao et al. BMC Cardiovascular Disorders
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now